Bestzyme’s MelliaTM Brazzein Receives FDA GRAS Status, Revolutionizing the Sweetener Market

Bestzyme’s MelliaTM Brazzein earns FDA GRAS status, paving the way for a healthier sweetener revolution. This zero-calorie, plant-derived alternative meets the growing demand for sugar reduction without sacrificing taste.

In a significant stride for the food and beverage industry, Bestzyme has announced that its revolutionary sweetener, MelliaTM Brazzein, has received the coveted “No Questions” letter from the U.S. Food and Drug Administration (FDA). This endorsement effectively places MelliaTM Brazzein on the list of substances that are Generally Recognized as Safe (GRAS), marking a pivotal moment for the company and the sweetener market at large.

The GRAS status is not merely a regulatory accolade; it is a testament to the safety and compliance of MelliaTM Brazzein as a general-purpose sweetener. This recognition follows the successful completion of Bestzyme’s Self-GRAS certification in July 2024 and underscores the company’s commitment to delivering safe, innovative products to the global market.

MelliaTM Brazzein is derived from Brazzein, a naturally occurring sweet protein found in the fruit of the West African plant Oubli (Pentadiplandra brazzeana Baillon). What sets it apart is its production through precision fermentation, a method that allows for sustainable and industrial-scale manufacturing.

This breakthrough not only ensures a pure and sweet taste but also supports the high sweetness and flavor-modifying functions of the product.

In today’s health-conscious world, the demand for sugar-reduction solutions is skyrocketing. Consumers are increasingly aware of the adverse effects of excessive sugar consumption, such as obesity, diabetes, and other related health issues.

MelliaTM Brazzein meets this demand by offering a zero-calorie sweetener alternative that does not affect blood sugar levels or disrupt the gut microbiome. It empowers consumers to make healthier dietary choices without compromising on taste.

This FDA approval opens the doors for MelliaTM Brazzein to confidently enter the global sweetener market. Its potential applications are vast, ranging from beverages and dairy products to confectionery, chocolate, health supplements, and catering.

The sweetener’s molecular structure as a protein also means it can be quickly digested into amino acids, offering an added health benefit.

For Bestzyme, MelliaTM Brazzein is more than just a sweetener; it is a milestone in the company’s expanding portfolio of functional proteins. A subsidiary of GenScript, Bestzyme specializes in the research, development, and industrialization of enzymes, functional proteins, and biopharmaceutical raw materials.

The company’s proprietary synthetic biology technology platform enables it to design molecules, engineer strains, and scale processes, resulting in high-performance products that cater to various industries, including food and nutrition, animal health, household care, and pharmaceuticals.

This achievement is a reflection of Bestzyme’s dedication to technological innovation and sustainability. By leveraging bio-based innovations, the company aims to drive green manufacturing practices and contribute to a more sustainable future.

The approval of MelliaTM Brazzein is a step forward in this mission, as it aligns with the global push towards healthier, more sustainable dietary options.

The burgeoning market for sugar-reducing ingredients is not just a trend but a necessity in the face of growing health concerns and regulatory pressures. Bestzyme’s entry into this market with MelliaTM Brazzein is timely and poised to make a significant impact.

As consumers become more discerning about what they consume, products like MelliaTM Brazzein offer a glimpse into the future of the food and beverage industry—a future where taste and health go hand in hand.

Looking ahead, Bestzyme is not resting on its laurels. The company is committed to advancing the frontiers of biology, developing a robust portfolio of high-value products, and empowering global consumers with healthier, sustainable choices.

With the FDA’s endorsement, MelliaTM Brazzein is set to become a cornerstone of this strategy, demonstrating the potential of science and innovation to transform the way we consume and enjoy food.

For more information about Bestzyme and its pioneering sweetener MelliaTM Brazzein, interested parties can explore further at their official website, highlighting the company’s ongoing commitment to innovation and sustainability in the food industry.